BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20424769)

  • 1. A pH-responsive fluorescence probe and photosensitiser based on a tetraamino silicon(IV) phthalocyanine.
    Jiang XJ; Lo PC; Yeung SL; Fong WP; Ng DK
    Chem Commun (Camb); 2010 May; 46(18):3188-90. PubMed ID: 20424769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phthalocyanine-polyamine conjugates as pH-controlled photosensitizers for photodynamic therapy.
    Jiang XJ; Lo PC; Tsang YM; Yeung SL; Fong WP; Ng DK
    Chemistry; 2010 Apr; 16(16):4777-83. PubMed ID: 20309976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pH-responsive fluorescent probe and photosensitiser based on a self-quenched phthalocyanine dimer.
    Ke MR; Ng DK; Lo PC
    Chem Commun (Camb); 2012 Sep; 48(72):9065-7. PubMed ID: 22864462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acid-cleavable phthalocyanine tetramer as an activatable photosensitiser for photodynamic therapy.
    Chow SY; Lo PC; Ng DK
    Dalton Trans; 2016 Aug; 45(33):13021-4. PubMed ID: 27396392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary studies of phthalocyanine sensitizers incorporated into human leukemia cells from two cell-lines.
    Wiktorowicz K; Cofta J; Dudkowiak A; Waszkowiak A; Frackowiak D
    Acta Biochim Pol; 2004; 51(3):703-10. PubMed ID: 15448732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Phycocyanin as a tumour-associated macrophage-targeted photosensitiser and a vehicle of phthalocyanine for enhanced photodynamic therapy.
    Wan DH; Zheng BY; Ke MR; Duan JY; Zheng YQ; Yeh CK; Huang JD
    Chem Commun (Camb); 2017 Apr; 53(29):4112-4115. PubMed ID: 28349131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disulfide-linked conjugate of ferrocenyl chalcone and silicon(IV) phthalocyanine as an activatable photosensitiser.
    Lau JT; Jiang XJ; Ng DK; Lo PC
    Chem Commun (Camb); 2013 May; 49(39):4274-6. PubMed ID: 23135340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-selective glutathione-responsive tris(phthalocyanine) as a smart photosensitiser for targeted photodynamic therapy.
    Chow SYS; Zhao S; Lo PC; Ng DKP
    Dalton Trans; 2017 Aug; 46(34):11223-11229. PubMed ID: 28795744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photophysical properties and photodynamic therapy activities of detonated nanodiamonds-BODIPY-phthalocyanines nanoassemblies.
    Matshitse R; Ngoy BP; Managa M; Mack J; Nyokong T
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():101-110. PubMed ID: 30851436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic modification of disulfonated aluminium phthalocyanine fluorescence in a macrophage cell line.
    Kunz L; Connelly JP; Woodhams JH; MacRobert AJ
    Photochem Photobiol Sci; 2007 Sep; 6(9):940-8. PubMed ID: 17721592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective mitochondria-targeting amphiphilic silicon(IV) phthalocyanines with axially ligated rhodamine B for photodynamic therapy.
    Zhao Z; Chan PS; Li H; Wong KL; Wong RN; Mak NK; Zhang J; Tam HL; Wong WY; Kwong DW; Wong WK
    Inorg Chem; 2012 Jan; 51(2):812-21. PubMed ID: 22191427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates.
    Zheng BY; Yang XQ; Zhao Y; Zheng QF; Ke MR; Lin T; Chen RX; Ho KKK; Kumar N; Huang JD
    Eur J Med Chem; 2018 Jul; 155():24-33. PubMed ID: 29852329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-aggregated silicon(IV) phthalocyanine-lactose conjugate for photodynamic therapy.
    Li D; Hu QY; Wang XZ; Li X; Hu JQ; Zheng BY; Ke MR; Huang JD
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127164. PubMed ID: 32291134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Biotinylated and Endoplasmic Reticulum-Targeted Glutathione-Responsive Zinc(II) Phthalocyanine for Targeted Photodynamic Therapy.
    Yu L; Wang Q; Yeung KW; Fong WP; Lo PC
    Chem Asian J; 2018 Nov; 13(22):3509-3517. PubMed ID: 29956487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-soluble non-aggregating zinc phthalocyanine and in vitro studies for photodynamic therapy.
    Makhseed S; Machacek M; Alfadly W; Tuhl A; Vinodh M; Simunek T; Novakova V; Kubat P; Rudolf E; Zimcik P
    Chem Commun (Camb); 2013 Dec; 49(95):11149-51. PubMed ID: 24040651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro photodynamic therapy on melanoma cell lines with phthalocyanine.
    Kolarova H; Nevrelova P; Bajgar R; Jirova D; Kejlova K; Strnad M
    Toxicol In Vitro; 2007 Mar; 21(2):249-53. PubMed ID: 17092686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-aggregated and tumour-associated macrophage-targeted photosensitiser for photodynamic therapy: a novel zinc(II) phthalocyanine containing octa-sulphonates.
    Li XS; Ke MR; Zhang MF; Tang QQ; Zheng BY; Huang JD
    Chem Commun (Camb); 2015 Mar; 51(22):4704-7. PubMed ID: 25692672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the photokilling effect of aluminum phthalocyanine in photodynamic therapy by conjugating with nitrogen-doped TiO2 nanoparticles.
    Pan X; Xie J; Li Z; Chen M; Wang M; Wang PN; Chen L; Mi L
    Colloids Surf B Biointerfaces; 2015 Jun; 130():292-8. PubMed ID: 25935263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual activatable photosensitizer toward targeted photodynamic therapy.
    Lau JT; Lo PC; Jiang XJ; Wang Q; Ng DK
    J Med Chem; 2014 May; 57(10):4088-97. PubMed ID: 24793456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugate of biotin with silicon(IV) phthalocyanine for tumor-targeting photodynamic therapy.
    Li K; Qiu L; Liu Q; Lv G; Zhao X; Wang S; Lin J
    J Photochem Photobiol B; 2017 Sep; 174():243-250. PubMed ID: 28802175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.